Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce healthcare costs. The company’s first product is the Lumicell Direct Visualization System, designed to provide real-time illumination of cancerous tissue within the breast cavity during the initial lumpectomy, potentially reducing repeat surgeries. Lumicell’s proprietary, pan-oncologic optical imaging agent is also being explored across a wide variety of solid tumor indications. The company aims to enhance the standard of care treatment by guiding the resection of additional cancer that may have otherwise been left behind.
Location: United States, Texas
Employees: 51-200
Phone: +1 617-404-1001
Total raised: $29.7M
Founded date: 2009
Investors 4
| Date | Name | Website |
| 15.04.2021 | Viceroy Ve... | viceven.co... |
| - | LaunchCapi... | launchcapi... |
| - | Rivas Capi... | rivascap.c... |
| - | Claridge V... | claridgevp... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.12.2017 | Series C | $28.7M | - |
| 07.01.2014 | - | $1M | - |
Mentions in press and media 10
| Date | Title | Description |
| 08.12.2017 | Term Sheet — Friday, December 8 | CHINA INVESTMENT OUTLOOK Happy Friday, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop I spoke with Tung about some of the emerging trends in China, the bike-sharing craze sweeping the country, and ... |
| 07.12.2017 | Lumicell Raises $28.7M in Series C Financing | Lumicell, Inc., a Wellesley, Mass.-based technology leader in the field of image-guided cancer surgery, raised $28.7M in Series C financing. Backers included Launch Capital and BlueIO. The company intends to use the funds to continue to dev... |
| 07.12.2017 | Lumicell Receives $28.7M Series C Round | WELLESLEY, MA, Lumicell has raised $28.7 million in Series C financing. >> Click here for more funding data on Lumicell >> To export Lumicell funding data to PDF and Excel, click here Lumicell, a technology leader in the ... |
| 07.12.2017 | Lumicell Raises $28.7M Series C | Leverages Broad Potential of LUM System with Drug, Device and Software for Real-time Detection of Tumor Tissue in Patients During Surgery WELLESLEY, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a technology leader in the field of image-guided ca... |
| 07.12.2017 | Lumicell Raises $28.7M Series C | Leverages Broad Potential of LUM System with Drug, Device and Software for Real-time Detection of Tumor Tissue in Patients During Surgery WELLESLEY, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a technology leader in the field of image-guided ca... |
| 14.08.2016 | Lumicell aims to reduce repeat surgeries in breast cancer | If successful, the device can prevent repeat operations, potentially saving the healthcare system nearly $1 billion annually, according to a statement from Lumicell. The cash infusion will fund the 400-person pivotal trial of the Lumicell M... |
| 06.03.2014 | Lumicell adds another $600,000 in funding | Imaging systems maker Lumicell Diagnostics amended a previously closed $1 million funding round after landing another $560,000 in financing from 2 new investors, regulatory filings show. Lumicell noted 7 unnamed investors who participated i... |
| 07.01.2014 | Lumicell closes $1M funding round | Lumicell Diagnostics Inc. hit the $1 million goal for its funding round. Wellesley, Mass.-based Lumicell is developing a hand-held imaging system designed to give physicians a better picture of the amount of cancer remaining at tumor sites ... |
| - | Lumicell aims to reduce repeat surgeries in breast cancer | Close-up view of a cancer cell One of the myriad problems with cancer surgery, particularly breast cancer surgery, is what is known as cancer at the margins. The problem that women who undergo such procedures often have to come for repeat p... |
| - | Lumicell | “Incomplete resections are leaving cancer behind. The Lumicell mission is to change the way cancer surgery is performed today.” |